The Raise Report
New funds with capital to deploy #020
Since we started releasing this data we have covered over 820 funds that have raised over $260b of fresh capital to deploy. Money does not seem to be an issue, getting out of those investors is, but why is that?
GLOBAL SUPER ACCELERATOR II IS NOW OPEN FOR APPLICATIONS
8-Week Execution and AI-First Accelerator
Panels: Rapid-fire operator & investor insights for clarity.
Master Classes: Battle-tested frameworks powering AI execution.
Workshops: Hands-on sprints that ship real builds.
Programme Kicks Off 25th Sept.
💸 New Funds Looking to Give You Cash
🚀 $7.6 billion Across 35 New Funds
Digital infrastructure, climate tech, biotech and AI lead the charge.
Where the Money is Going
🌍 Geography at a Glance
North America (35 % of fund $ ~ $2.66 billion) – Continued strong interest in digital infrastructure, defence tech and litigation finance drives large vehicle launches in the US and Canada
Europe (4 % of fund $ ~ $285 million) – Specialist venture capital trusts and female-focused catalysts back life sciences and gender equity in the UK and broader Europe
Asia-Pacific (20 % of fund $ ~ $1.54 billion) – State-backed AI and biotech vehicles in China combine with university spin-out and cleantech funds across Australia and New Zealand
Latin America & Caribbean (1 % of fund $ ~ $75.8 million) – Impact-driven circular economy funds tackle plastic pollution, scaling recycling and waste-management solutions
Rest of the World – Israel, Canada and global evergreen funds support resilient tech ventures, medtech and litigation finance.
🎯 Sector Priorities
Digital Infrastructure (33 % of funds by $)
Backed by vehicles targeting energy, logistics and resilient supply chains tied to digital backbone companies.
Climate Tech (21 % of funds by $)
Fund-of-funds and direct vehicles invest in mitigation, adaptation and circular economy ventures to decarbonise industry.
Biotechnology (17 % of funds by $)
“Single-asset” biotech hubs and life-sciences specialists drive clinical proof-of-concept investments in oncology and therapeutics.
Artificial Intelligence (12 % of funds by $)
State-backed and corporate CVCs pour capital into AI model development, data infrastructure and AI-first platform ventures.
Other Sectors (17 % by $) – Include fintech, defence tech, medtech and legal finance, focusing on digital payments, national security innovation and specialized investment streams.
🚀 Investment Stages
Early Stage — 71 % of new funds (25 of 35)
Predominantly seed and Series A vehicles championing digital infrastructure, climate tech and biotech start-ups poised for scale.
Growth Stage — 29 % of new funds (10 of 35)
Large-cap and evergreen funds target growth-stage AI, defence tech, private credit and life-sciences platforms.
What This Means for Founders
North America remains the largest source of capital, with digital infrastructure and defence tech hottest among investors. Founders should tailor pitches to regional trends—leaning on AI and climate credentials in Asia-Pacific, while tapping impact-focused recycling and gender-equity funds in emerging markets—to maximise fundraising success.